galactosamine has been researched along with biochanin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Li, Y; Liu, X; Qi, J; Wang, T; Zhang, P | 1 |
1 other study(ies) available for galactosamine and biochanin a
Article | Year |
---|---|
Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Topics: Animals; Anti-Inflammatory Agents; Carrier Proteins; Chemical and Drug Induced Liver Injury; Galactosamine; Genistein; Heme Oxygenase-1; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Liver; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Thioredoxins; Tumor Necrosis Factor-alpha | 2016 |